Previous
Manchester United
Paris Saint-Germain
1:00 AM UTC Jul 30, 2015
Game Details
MLS All-Stars
Tottenham Hotspur
1:00 AM UTC Jul 30, 2015
Game Details
Rapid Vienna
Ajax Amsterdam
7:05 PM UTC
Leg 1
Game Details
Celtic
FK Qarabag
6:45 PM UTC
Leg 1
Game Details
York City
Newcastle United
6:45 PM UTC
Game Details
Jablonec
FC Copenhagen
4:00 PM UTC
Leg 1
Game Details
U.A.N.L
River Plate
1:00 AM UTC Jul 30, 2015
Leg 1
Game Details
Next

LIVE: Spurs seek 'Chicharito' move

Transfer Talk
Read

Mourinho: Prem harder now than 2004

Chelsea
Read

Zidane: Di Maria can help PSG

Transfers
Read

Italian pair have drug-related bans overturned

Italian soccer players Daniele Mannini and Davide Possanzini have had their one-year bans for arriving late to a doping test overturned, the Court of Arbitration for Sport (CAS) said on Monday.

The CAS provisionally lifted the bans in March while the case was re-examined and the Lausanne-based court said in a statement that it had now decided to revert to the already-served 15-day bans originally imposed by the Italian Olympic Committee (CONI).

"The CAS confirms the initial decision of CONI: 15 days' ineligibility," read a statement.

The World Anti-Doping Agency (WADA) challenged the original sentence the duo were given for being late to doping control when playing for Serie B club Brescia in 2007 and had it increased at the CAS in January.

The heavier bans caused outrage in Italy and the country's football federation (FIGC) asked the CAS to reconsider, given that neither player had failed a drugs test.

Winger Mannini, now with Serie A's Sampdoria, and striker Possanzini were ordered to attend a dressing-room meeting in December 2007 following Brescia's third successive defeat, leading to their late arrival for the doping tests.

Comments

Use a Facebook account to add a comment, subject to Facebook's Terms of Service and Privacy Policy. Your Facebook name, photo & other personal information you make public on Facebook will appear with your comment, and may be used on ESPN's media platforms. Learn more.